388870 파로스아이바이오

기본 정보

• 섹터: KOSDAQ:일반서비스
• 시가총액: 687억원 (2026-06-30 기준)
• 첫 등장: 2026-06-05 (누적 2일)
• 태그: 매크로/IT소프트웨어 · 매크로/바이오헬스 · 신약개발 · 항암 · AI신약 · 희귀질환 · 바이오
• 네이버 금융: 🔗

기업개요

• 동사는 2016년 설립되어 2023년 코스닥에 기술성장기업으로 상장한 중소·벤처기업임.
• 희귀·난치성 질환(특히 항암)에 대한 혁신 신약을 개발하는 연구개발 전문기업으로, 핵심기술로서 AI (인공지능) 기반 신약 개발 플랫폼인 케미버스(Chemiverse) 기술을 보유하고 있음.
• 케미버스를 통해 신약 개발 기간 단축과 비용 절감을 실현할 사업모델로 초기 신약후보물질부터 임상단계까지 전 주기 혁신신약 파이프라인을 구축하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-14	5,800	5,670	🔵 -2.24%	—	×0.5	🟡 금투	-0.3억	-0.3	+0.0	+0.4	+0.0	-0.1	+0.0
2026-08-13	5,840	5,800	🔵 -0.68%	—	×0.6	⚫ 그외	-0.1억	-0.1	+0.0	-0.5	+0.0	+0.2	+0.3
2026-08-12	6,050	5,840	🔵 -3.47%	—	×0.5	🔻 개인	-0.3억	-0.3	+0.0	+0.1	+0.0	+0.1	+0.0
2026-08-11	5,890	6,050	🔴 +2.72%	—	×0.9	🟡 금투	-0.9억	-0.9	+0.0	+0.5	+0.0	+0.4	+0.0
2026-08-10	5,510	5,890	🔴 +6.90%	—	×0.6	🟢 외인	+0.9억	+0.9	+0.0	-0.2	+0.0	-0.8	+0.1
2026-08-07	5,490	5,510	🔴 +0.36%	—	×0.3	🟢 외인	+0.1억	+0.1	+0.0	+0.1	+0.0	-0.2	+0.0
2026-08-06	5,390	5,490	🔴 +1.86%	—	×0.7	🟡 금투	+0.0억	+0.0	+0.0	+0.2	+0.0	-0.2	+0.0
2026-08-05	5,390	5,390	⚪ +0.00%	—	×0.4	🔻 개인	-0.4억	-0.4	+0.0	-0.2	+0.0	+0.3	+0.2
2026-08-04	4,900	5,390	🔴 +10.00%	—	×0.9	🟢 외인	+1.2억	+1.2	+0.0	+0.1	+0.0	-1.4	+0.0
2026-08-03	4,735	4,900	🔴 +3.48%	—	×1.0	🟢 외인	+0.2억	+0.2	+0.0	-0.1	+0.0	-0.3	+0.1
2026-07-31	4,370	4,735	🔴 +8.35%	—	×0.9	⚫ 그외	+0.2억	+0.2	+0.0	-0.0	+0.0	-0.8	+0.6
2026-07-30	4,310	4,370	🔴 +1.39%	—	×3.5	🟢 외인	+0.9억	+0.9	+0.0	+0.2	+0.0	-1.1	+0.0
2026-07-29	4,715	4,310	🔵 -8.59%	—	×2.2	🟢 외인	+1.1억	+1.1	+0.0	+0.0	+0.0	-1.1	+0.0
2026-07-28	5,120	4,715	🔵 -7.91%	—	×1.0	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.1	+0.0
2026-07-27	5,000	5,120	🔴 +2.40%	—	×0.7	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-07-24	5,100	5,000	🔵 -1.96%	—	×0.5	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-23	4,745	5,100	🔴 +7.48%	—	×1.0	🟢 외인	+1.1억	+1.1	+0.0	-0.3	+0.0	-0.8	+0.0
2026-07-22	4,980	4,745	🔵 -4.72%	—	×0.8	🔻 개인	-0.6억	-0.6	+0.0	-0.1	+0.0	+0.7	+0.0
2026-07-21	5,060	4,980	🔵 -1.58%	—	×1.2	🔻 개인	-0.6억	-0.6	+0.0	+0.2	+0.0	+0.3	+0.0
2026-07-20	5,070	5,060	🔵 -0.20%	—	×1.0	🔻 개인	-0.2억	-0.2	+0.0	+0.1	+0.0	+0.2	+0.0
2026-07-16	5,120	5,070	🔵 -0.98%	—	×0.7	🟢 외인	+0.6억	+0.6	+0.0	+0.1	+0.0	-0.6	+0.0
2026-07-15	5,000	5,120	🔴 +2.40%	—	×0.7	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.3	+0.0
2026-07-14	5,010	5,000	🔵 -0.20%	—	×1.5	🟢 외인	+0.2억	+0.2	+0.0	-0.1	+0.0	-0.2	+0.0
2026-07-10	5,070	5,320	🔴 +4.93%	—	×0.4	🟢 외인	+0.4억	+0.4	+0.0	-0.3	-0.4	+0.3
2026-07-09	5,100	5,070	🔵 -0.59%	—	×0.9	🟢 외인	+0.5억	+0.5	+0.0	+0.3	-1.0	+0.2
2026-07-08	5,650	5,100	🔵 -9.73%	—	×0.7	🔻 개인	-0.5억	-0.5	+0.0	-0.3	+0.8	+0.0
2026-07-07	5,430	5,650	🔴 +4.05%	—	×0.5	🟡 금투	-0.1억	-0.1	+0.0	+0.2	-0.1	-0.0
2026-07-06	5,240	5,430	🔴 +3.63%	—	×0.6	🔻 개인	-0.4억	-0.4	+0.0	+0.0	+0.5	-0.1
2026-07-03	5,210	5,240	🔴 +0.58%	—	×0.7	🟢 외인	+0.7억	+0.7	+0.0	-0.0	-0.7	+0.0
2026-07-02	5,420	5,210	🔵 -3.87%	—	×0.5	🟢 외인	+0.2억	+0.2	+0.0	-0.4	+0.1	+0.1
2026-07-01	5,310	5,420	🔴 +2.07%	—	×0.5	🟡 금투	-0.3억	-0.3	+0.0	+0.5	-0.2	+0.0
2026-06-30	5,590	5,310	🔵 -5.01%	—	×0.3	🔻 개인	-0.2억	-0.2	+0.0	-0.0	+0.2	+0.0
2026-06-29	5,090	5,590	🔴 +9.82%	—	×0.5	🟢 외인	+1.3억	+1.3	+0.0	-0.1	-1.1	-0.0
2026-06-26	5,380	5,090	🔵 -5.39%	—	×0.8	🔻 개인	+0.3억	+0.3	+0.0	-0.1	+0.5	-0.8
2026-06-25	5,560	5,380	🔵 -3.24%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	+0.1	-0.4	+0.1
2026-06-24	5,550	5,560	🔴 +0.18%	—	×0.4	🟢 외인	+1.2억	+1.2	+0.0	-0.0	-1.1	+0.0
2026-06-23	6,000	5,550	🔵 -7.50%	—	×0.4	🟢 외인	+0.1억	+0.1	+0.0	-0.1	+0.1	+0.0
2026-06-22	6,260	6,000	🔵 -4.15%	—	×0.5	🟡 금투	-0.2억	-0.2	+0.0	+0.2	+0.1	-0.1
2026-06-19	6,550	6,260	🔵 -4.43%	—	×0.4	🟢 외인	+0.5억	+0.5	+0.0	+0.0	-0.6	+0.0
2026-06-18	7,000	6,550	🔵 -6.43%	—	×0.8	🔻 개인	-1.4억	-1.4	+0.0	-0.1	+1.5	+0.1
2026-06-17	6,150	7,000	🔴 +13.82%	—	×2.1	⚫ 그외	-1.5억	-1.5	+0.0	+0.1	+0.1	+1.3
2026-06-16	6,080	6,150	🔴 +1.15%	—	×0.2	🟢 외인	+0.4억	+0.4	+0.0	-0.0	-0.4	+0.0
2026-06-15	6,010	6,080	🔴 +1.16%	—	×0.6	⚫ 그외	-1.4억	-1.4	+0.0	-0.0	+0.6	+0.9
2026-06-12	6,170	6,010	🔵 -2.59%	—	×1.0	⚫ 그외	-0.1억	-0.1	+0.0	+0.1	-1.4	+1.5
2026-06-11	6,080	6,170	🔴 +1.48%	—	×0.4	🟢 외인	+0.3억	+0.3	+0.0	-0.0	-0.5	+0.2
2026-06-10	6,310	6,080	🔵 -3.65%	—	×0.7	🔻 개인	-0.9억	-0.9	+0.0	-0.1	+1.0	-0.0
2026-06-09	6,380	6,310	🔵 -1.10%	—	×1.0	🟢 외인	+0.7억	+0.7	+0.0	+0.0	-0.9	+0.2
2026-06-08	7,820	6,380	🔵 -18.41%	—	×4.0	🔻 개인	-2.2억	-2.2	+0.0	+0.0	+2.3	-0.1
2026-06-05	6,300	7,820	🔴 +24.13%	—	×6.5	🔻 개인	-4.0억	-4.0	+0.0	+0.1	+3.6	+0.2
2026-06-04	6,060	6,300	🔴 +3.96%	—	×0.6	🔻 개인	-0.1억	-0.1	+0.0	-0.2	+0.1	+0.1
2026-06-02	6,290	6,060	🔵 -3.66%	—	×0.6	🟡 금투	+0.1억	+0.1	+0.0	+0.2	-0.3	+0.0
2026-06-01	6,300	6,290	🔵 -0.16%	—	×1.2	🔻 개인	-0.9억	-0.9	+0.0	-0.0	+0.6	+0.4
2026-05-29	6,630	6,300	🔵 -4.98%	—	×0.8	🟢 외인	+0.4억	+0.4	+0.0	+0.0	-0.4	+0.0
2026-05-28	6,970	6,630	🔵 -4.88%	—	×0.6	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.1	-0.0
2026-05-27	6,880	6,970	🔴 +1.31%	—	×0.9	🔻 개인	-1.1억	-1.1	+0.0	+0.0	+1.2	-0.0
2026-05-26	7,100	6,880	🔵 -3.10%	—	×0.6	🔻 개인	-2.3억	-2.3	+0.0	-0.0	+1.8	+0.5
2026-05-22	6,560	7,100	🔴 +8.23%	—	×0.6	🟢 외인	+1.0억	+1.0	+0.0	-0.1	-1.0	+0.1

일자별 사유 (최신 위)

2026-08-04

• 사유: —
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +128억)
• 매크로 원인: 코스닥 6%대 급반등 속 경영진 자사주 매입·임상데이터·기술이전 호재로 바이오 전반 강세 (보통)

2026-06-17

• 사유: 바이오 USA 피칭기업 선정·글로벌 기술이전 논의
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +109억)
• 매크로 원인: 바이오 USA 개막발 기술이전 기대 + FDA·임상 호재로 소외됐던 제약바이오 일제 반등 (보통)

2026-06-05

• 사유: AI 신약개발 정부 과제 수주+대표 자사주 매입 책임경영
• 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +10.8억)
• 매크로 원인: 美 증시 제약·바이오 훈풍 속 개별 호재(비만약·AI신약·검진AI) 겹쳐 동반 급등 (보통)